You are here

Japan's Takeda on the hunt for new drugs to support growth

BT_20170123_CHTAKEDA7XEJ_2704161.jpg
The Asia-Pacific alone bears 25 per cent of the global disease burden, says Gordon Cameron, Takeda area vice-president.

Singapore

AFFORDABILITY of drugs is the single biggest challenge for not just governments looking to keep a lid on healthcare costs, but also for drug makers hunting for growth and pressured to find new treatments to cope with the rapid rise in patients' need for medicines.

The

sentifi.com

Market voices on:

Powered by GET.comGetCom